Hepatitis Current Events | Hepatitis News | 4
|
| Page
4 of
11 |
218 Results |
|
|
|
Sort By:
Page Views | Date |
Using math to understand hep. C: Patterns paint picture of who will respond to treatment
Genetic patterns are like the tea leaves in the bottom of a cup for predicting which patients are likely to respond to medical therapy for life-threatening viruses such as hepatitis C, Saint Louis University researchers have discovered. view more (2008-12-23)
Are you one of the few that respond to treatment for hepatitis C?
In some patients resistance to treatment for hepatitis C can be detected as early as the first three days of treatment, according to a team of scientists in a recent article published in Hepatology. This knowledge should help clinicians predict the effectiveness of individual treatments and consequently decide who should go through such a regimen.... view more... (2003-06-24)
Test predicts risk of liver scarring after transplant, study shows
An estimated 20 percent of people with chronic hepatitis C who receive a liver transplant will develop advanced cirrhosis, scarring of the new organ severe enough to impair its ability to function normally within five years of transplantation. view more (2005-10-06)
How to tell if a hepatitis-C-virus-infected patient will respond to therapy
Hepatitis C virus (HCV) causes hepatitis and increased risk of developing liver cancer. Current treatments are expensive, have severe side effects, and fail in about half the patients treated. view more (2008-12-23)
Genetic hint for ridding the body of hepatitis C
More than seventy percent of people who contract Hepatitis C will live with the virus that causes it for the rest of their lives and some will develop serious liver disease including cancer. view more (2009-09-17)
Molecular 'on/off switch' controls immune defenses against viruses
Much like flipping a light switch, the hepatitis C virus turns on human immune defenses upon entering the body but also turns off those defenses by manipulating interaction of key cellular proteins, UT Southwestern Medical Center researchers have found. view more (2006-12-26)
Most chronic hepatitis C sufferers will develop cirrhosis in later life
Nearly 80 percent of chronic hepatitis C sufferers who have the disease for several decades will develop cirrhosis or end-stage liver disease later in life. view more (2005-09-01)
MRI predicts liver fibrosis, study says
Moderate to severe chronic liver disease can be predicted with the use of diffusion-weighted MRI (DWI), according to a recent study conducted by researchers at New York University Medical Center in New York, NY. view more (2007-10-24)
Circulation of 'disaster myths' in Haiti could hinder appropriate disposal of bodies
Myths about the infectious disease threat posed by dead bodies could lead to insensitive and inappropriate treatment of victims' bodies following the floods in Haiti, and need to be checked, according to a public health researcher who has studied the potential risks at length. view more (2004-09-30)
Korean mummies may provide clues to combat hepatitis B
Mummies that have recently been unearthed in South Korea may provide clues on how to combat hepatitis B. view more (2007-07-26)
Are you one of the few that respond to treatment for hepatitis C? - part 2
In patients being treated for hepatitis C the analysis of amino alanine transferase (ALT), a liver-produced enzyme, can help to predict if therapy will be successful, claims a team of researchers in the August issue of Hepatology2. The group of investigators propose that in some patients, it is possible, already in the first 48... view more... (2003-08-19)
First evidence for DNA-based vaccination against chronic hepatitis C
The first-proof-of-concept for a DNA-based therapeutic vaccination against chronic hepatitis C was announced today at EASL 2009, the Annual Meeting of the European Association for the Study of the Liver in Copenhagen, Denmark. view more (2009-04-23)
What is the more suitable for early detection of low abundant lamivudine-resistant mutants?
Lamivudine is an effective antiviral agent for treatment of patients with chronic hepatitis B and advanced liver diseases. However, long-term lamivudine monotherapy leads to the emergence of lamivudine-resistant hepatitis B virus (HBV) mutants in some patients chronically infected with HBV. view more (2008-01-17)
HepCgen genotyping service helps fight Hepatitis C, a 'silent epidemic'
Southampton UK, July 22, 2003 Genotyping provides route to tailored treatment at lower cost with less side effects A new centralised genotyping service that enables clinicians to differentiate between types of hepatitis C infections is poised to improve treatment for patients with Hepatitis C, a severely under treated viral infection in the UK.... view more... (2003-07-22)
Risk of lymphoma increases with hepatitis C virus infection
People infected with the hepatitis C virus (HCV) are at an increased risk of developing certain lymphomas (cancers of the lymphatic system), according to a study published in the May 8, 2007, issue of the Journal of the American Medical Association. view more (2007-05-09)
Stanford scientist to discuss new approach to treating hepatitis C virus
Last year Peter Sarnow, PhD, professor of microbiology and immunology at the Stanford University School of Medicine, identified a previously unknown mechanism that the hepatitis C virus uses to replicate, yielding a promising new approach to combating the disease-causing virus. view more (2006-04-06)
Heart transplant from organ donor with hepatitis C associated with decreased survival
Heart transplant patients who receive a donor heart from a person with hepatitis C have a lower rate of survival. view more (2006-10-18)
Can liver cirrhosis be partially cured?
The diffusion of hepatitis C virus infection worldwide is astonishing. Liver cirrhosis is present in at least 10-20% of these infected patients, with highly increasing health care and emotional costs. view more (2007-10-11)
Varicella zoster infection causes severe autoimmune hepatitis
Autoimmune hepatitis (AIH) is a chronic liver inflammation of unknown etiology that is characterized by the presence of circulatory autoantibodies and ongoing liver tissue damage. view more (2009-03-03)
New research promises cure by mouth
A researcher at Aston University in Birmingham has become the first in the UK to investigate a new type of vaccination delivery that could revolutionise how we are protected against diseases including flu, hepatitis and, most excitingly, cancer. Dr Yvonne Perrie from the School of Life & Health Sciences has received a research grant from The... view more... (2002-12-02)
|
|
| Page
4 of
11 |
218 Results |
|
|
|
Sort By:
Page Views | Date |
|
